Arun, Nitali, Anand Dev, and V. K. Singh. “A Study on the Efficacy of 24 Weeks of Sofosbuvir, Daclatasvir With Ribaravin in the Treatment of Chronic Hepatitis C Patients With Cirrhosis, Genotype 1 and 3.”. Asian Journal of Medical Research 7, no. 4 (January 20, 2019): ME25-ME28. Accessed May 6, 2024. https://aijournals.com/index.php/ajmr/article/view/434.